Upperton will apply its expertise to enable the next generation of Adenovirus-vectored vaccines to be delivered without needles.
Discover more about our team. In this Spotlight, meet our Project Coordinator, Sophie Skinner, on her journey with Upperton.
We’re delighted to have been shortlisted in two major categories at the Pharma Industry Awards UK 2025, recognising our growth.
We’re delighted to announce that we’ve won the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.
Discover the critical product decisions in sterile drug formulation development. Learn how planning with your CDMO can streamline your path.
Discover why project management is the critical success factor for CDMO collaborations. Explore Upperton’s approach.
Nikki Whitfield, CEO of Upperton, has received the ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025
We’re delighted to announce that Upperton has officially been accredited as one of The Sunday Times Best Places to Work 2025
Our Approach Project Initiation and Onboarding We typically initiate projects within two to three weeks of proposal acceptance. During this time, we manage project onboarding and procure any necessary materials. Our analytical team plays a crucial role in onboarding new methods, confirming their suitability, and ensuring readiness for the subsequent stages of your project. This … Read more
Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.
Speak with our team of experts and set up a discovery call to discuss your project in more detail.